Yashna Singh
Overview
Explore the profile of Yashna Singh including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
82
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Njeim R, Abureesh M, Singh Y, El Douaihy Y
ACG Case Rep J
. 2025 Mar;
12(3):e01633.
PMID: 40028453
Plasmablastic lymphoma (PBL) is a rare, aggressive subtype of diffuse large B-cell lymphoma that has usually been associated with human immunodeficiency virus and Ebstein-Barr virus infections. Commonly seen in the...
2.
Garrett N, Tapley A, Hudson A, Dadabhai S, Zhang B, Mgodi N, et al.
EClinicalMedicine
. 2025 Feb;
80:103054.
PMID: 39902315
Background: With limited access to mRNA COVID-19 vaccines in lower income countries, and people living with HIV (PLWH) largely excluded from clinical trials, Part A of the multicentre CoVPN 3008...
3.
Bekker L, Das M, Abdool Karim Q, Ahmed K, Batting J, Brumskine W, et al.
N Engl J Med
. 2024 Jul;
391(13):1179-1192.
PMID: 39046157
Background: There are gaps in uptake of, adherence to, and persistence in the use of preexposure prophylaxis for human immunodeficiency virus (HIV) prevention among cisgender women. Methods: We conducted a...
4.
Psaros C, Goodman G, Lee J, Rice W, Kelley C, Oyedele T, et al.
J Int AIDS Soc
. 2024 May;
27(5):e26252.
PMID: 38783534
Introduction: HPTN 083 demonstrated the superiority of long-acting cabotegravir (CAB-LA) versus daily oral emtricitabine/tenofovir disoproxil fumarate (TDF/FTC) as pre-exposure prophylaxis (PrEP) among cisgender men and transgender women who have sex...
5.
Marzinke M, Hanscom B, Wang Z, Safren S, Psaros C, Donnell D, et al.
Lancet HIV
. 2023 Oct;
10(11):e703-e712.
PMID: 37783219
Background: The HIV Prevention Trials Network (HPTN) 083 trial showed that long-acting injectable cabotegravir was more effective than tenofovir disoproxil fumarate plus emtricitabine in preventing HIV in cisgender men and...
6.
Dass M, Singh Y, Ghai M
Curr Microbiol
. 2023 Jul;
80(9):299.
PMID: 37491404
Microbial communities present in body fluids can assist in distinguishing between types of body fluids. Metagenomic studies have reported bacterial genera which are core to specific body fluids and are...
7.
Dickinson L, Walimbwa S, Singh Y, Kaboggoza J, Kintu K, Sihlangu M, et al.
Clin Infect Dis
. 2020 Dec;
73(5):e1200-e1207.
PMID: 33346335
Background: Rapid reduction in human immunodeficiency virus (HIV) load is paramount to prevent peripartum transmission in women diagnosed late in pregnancy. We investigated dolutegravir population pharmacokinetics in maternal plasma, umbilical...
8.
Waitt C, Orrell C, Walimbwa S, Singh Y, Kintu K, Simmons B, et al.
PLoS Med
. 2019 Sep;
16(9):e1002895.
PMID: 31539371
Background: The global transition to use of dolutegravir (DTG) in WHO-preferred regimens for HIV treatment is limited by lack of knowledge on use in pregnancy. Here we assessed the relationship...
9.
Singh D, Lau M, Ayers T, Singh Y, Akingbola O, Barbiero L, et al.
Clin Pediatr (Phila)
. 2015 Aug;
55(9):867-70.
PMID: 26283219
No abstract available.